Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: A narrative review

Judith E. K. R. Hentzen; Steven J. de Jongh; Patrick H. J. Hemmer; Willemijn Y. van der Plas; Gooitzen M. van Dam; Schelto Kruijff

doi:10.1002/jso.25106

Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: A narrative review

Judith E. K. R. Hentzen
, Steven J. de Jongh
, Patrick H. J. Hemmer
, Willemijn Y. van der Plas
, Gooitzen M. van Dam
, Schelto Kruijff^*

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

16 Citations (Scopus)

337 Downloads (Pure)

Abstract

Patients with peritoneal carcinomatosis (PC) from colorectal origin may undergo cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) as a curative approach. One major prognostic factor that affects survival is completeness of cytoreduction. Molecular Fluorescence Guided Surgery (MFGS) is a novel intraoperative imaging technique that may improve tumor identification in the future, potentially preventing over- and under-treatment in these patients. This narrative review outlines a chronological overview of MFGS development in patients with PC of colorectal origin.

Original language	English
Pages (from-to)	332-343
Number of pages	12
Journal	Journal of Surgical Oncology
Volume	118
Issue number	2
DOIs	https://doi.org/10.1002/jso.25106
Publication status	Published - 1-Aug-2018

Keywords

colorectal cancer
molecular fluorescence-guided surgery
peritoneal carcinomatosis
review
HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY
ENDOTHELIAL GROWTH-FACTOR
GLOBAL CANCER STATISTICS
SENTINEL LYMPH-NODE
INDOCYANINE-GREEN
CYTOREDUCTIVE SURGERY
PHOTODYNAMIC THERAPY
CARCINOEMBRYONIC ANTIGEN
PHASE-I
SYSTEMIC CHEMOTHERAPY

Access to Document

10.1002/jso.25106Licence: CC BY-NC

Molecular fluorescence‐guided surgery of peritoneal carcinomatosis of colorectal originFinal publisher's version, 331 KBLicence: CC BY-NC

Handle.net

Persistent link

Cite this

@article{e42dd38857034e72a77e02ee5a4b43f7,

title = "Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: A narrative review",

abstract = "Patients with peritoneal carcinomatosis (PC) from colorectal origin may undergo cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) as a curative approach. One major prognostic factor that affects survival is completeness of cytoreduction. Molecular Fluorescence Guided Surgery (MFGS) is a novel intraoperative imaging technique that may improve tumor identification in the future, potentially preventing over- and under-treatment in these patients. This narrative review outlines a chronological overview of MFGS development in patients with PC of colorectal origin.",

keywords = "colorectal cancer, molecular fluorescence-guided surgery, peritoneal carcinomatosis, review, HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY, ENDOTHELIAL GROWTH-FACTOR, GLOBAL CANCER STATISTICS, SENTINEL LYMPH-NODE, INDOCYANINE-GREEN, CYTOREDUCTIVE SURGERY, PHOTODYNAMIC THERAPY, CARCINOEMBRYONIC ANTIGEN, PHASE-I, SYSTEMIC CHEMOTHERAPY",

author = "Hentzen, \{Judith E. K. R.\} and \{de Jongh\}, \{Steven J.\} and Hemmer, \{Patrick H. J.\} and \{van der Plas\}, \{Willemijn Y.\} and \{van Dam\}, \{Gooitzen M.\} and Schelto Kruijff",

year = "2018",

month = aug,

day = "1",

doi = "10.1002/jso.25106",

language = "English",

volume = "118",

pages = "332--343",

journal = "Journal of Surgical Oncology",

issn = "0022-4790",

publisher = "Wiley",

number = "2",

}

TY - JOUR

T1 - Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin

T2 - A narrative review

AU - Hentzen, Judith E. K. R.

AU - de Jongh, Steven J.

AU - Hemmer, Patrick H. J.

AU - van der Plas, Willemijn Y.

AU - van Dam, Gooitzen M.

AU - Kruijff, Schelto

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Patients with peritoneal carcinomatosis (PC) from colorectal origin may undergo cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) as a curative approach. One major prognostic factor that affects survival is completeness of cytoreduction. Molecular Fluorescence Guided Surgery (MFGS) is a novel intraoperative imaging technique that may improve tumor identification in the future, potentially preventing over- and under-treatment in these patients. This narrative review outlines a chronological overview of MFGS development in patients with PC of colorectal origin.

AB - Patients with peritoneal carcinomatosis (PC) from colorectal origin may undergo cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) as a curative approach. One major prognostic factor that affects survival is completeness of cytoreduction. Molecular Fluorescence Guided Surgery (MFGS) is a novel intraoperative imaging technique that may improve tumor identification in the future, potentially preventing over- and under-treatment in these patients. This narrative review outlines a chronological overview of MFGS development in patients with PC of colorectal origin.

KW - colorectal cancer

KW - molecular fluorescence-guided surgery

KW - peritoneal carcinomatosis

KW - review

KW - HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY

KW - ENDOTHELIAL GROWTH-FACTOR

KW - GLOBAL CANCER STATISTICS

KW - SENTINEL LYMPH-NODE

KW - INDOCYANINE-GREEN

KW - CYTOREDUCTIVE SURGERY

KW - PHOTODYNAMIC THERAPY

KW - CARCINOEMBRYONIC ANTIGEN

KW - PHASE-I

KW - SYSTEMIC CHEMOTHERAPY

U2 - 10.1002/jso.25106

DO - 10.1002/jso.25106

M3 - Review article

SN - 0022-4790

VL - 118

SP - 332

EP - 343

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

IS - 2

ER -

Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: A narrative review

Abstract

Keywords

Access to Document

Handle.net

Fingerprint

Cite this